Doxribtimine

Doxribtimine

SCHEMBL4277671

Cc1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O.O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

P

The experimentally established mechanism targets of Doxribtimine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.52
LMNA P02545 2/20 0.52
MEN1 O00255 1/20 0.52
ABL1 P00519 1/20 0.52
PKM P14618 1/20 0.52
IDE P14735 1/20 0.52
MAPK1 P28482 1/20 0.52
KMT2A Q03164 1/20 0.52
RIN1 Q13671 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
F2 P00734 1/20 0.52
TK2 O00142 2/20 0.48
TK1 P04183 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38652488 0.88 F2 (0.64) TDP1F2TK1
Biotin SCHEMBL523980 0.83 TDP1 (0.51) TDP1LMNAMEN1ABL1PKM
Doxribtimine SCHEMBL2985309 0.81 TK1 (0.65) LMNATK2TK1SMN1; SMN2
SCHEMBL6534840 0.80 TK1 (0.46) TDP1LMNAMEN1ABL1PKM
Doxribtimine SCHEMBL20214217 0.79 TK1 (0.69) LMNATK2TK1SMN1; SMN2
Doxribtimine SCHEMBL28151767 0.78 TK1 (0.72) LMNAPKMTK2TK1SMN1; SMN2
Doxribtimine SCHEMBL8023808 0.78 TK1 (0.72) LMNAPKMTK2TK1SMN1; SMN2
Doxribtimine SCHEMBL993448 0.78 TK1 (0.67) LMNATK2TK1SMN1; SMN2
Doxribtimine SCHEMBL14596596 0.78 TK1 (0.73) LMNAPKMTK2TK1SMN1; SMN2
Doxribtimine SCHEMBL10382149 0.78 TK1 (0.73) LMNAPKMTK2TK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230193273-A1 SIGNAL BOOST CASCADE ASSAY VEDABIO, INC. 2023-06-22 US claimed
WO-2023114090-A2 SIGNAL BOOST CASCADE ASSAY LABSIMPLY, INC. (US) 2023-06-22 WO claimed
US-20240218364-A1 SIGNAL BOOST CASCADE ASSAY VEDABIO, INC. 2024-07-04 US disclosed
EP-3707273-B1 REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS TWINSTRAND BIOSCIENCES INC (US) 2024-04-10 EP disclosed
US-20240076716-A1 REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS TWINSTRAND BIOSCIENCES, INC. 2024-03-07 US disclosed
US-20240035028-A1 SIGNAL BOOST CASCADE ASSAY VEDABIO, INC. 2024-02-01 US disclosed
US-11884921-B2 Signal boost cascade assay VEDABIO, INC. (US) 2024-01-30 US disclosed
US-20230279375-A1 SIGNAL BOOST CASCADE ASSAY VEDABIO, INC. 2023-09-07 US disclosed
US-11739367-B2 Reagents and adapters for nucleic acid sequencing and methods for making such reagents and adapters TWINSTRAND BIOSCIENCES, INC. (US) 2023-08-29 US disclosed
US-20230235393-A1 METHODS OF ENRICHING FOR TARGET NUCLEIC ACID MOLECULES AND USES THEREOF QIAGEN SCIENCES, LLC 2023-07-27 US disclosed
US-20230193273-A1 SIGNAL BOOST CASCADE ASSAY VEDABIO, INC. 2023-06-22 US disclosed
WO-2021252867-A2 METHODS OF ENRICHING FOR TARGET NUCELIC ACID MOLECULES AND USES THEREOF QIAGEN SCIENCES, LLC (US) 2021-12-16 WO disclosed
EP-3765063-A1 METHODS AND REAGENTS FOR ENRICHMENT OF NUCLEIC ACID MATERIAL FOR SEQUENCING APPLICATIONS AND OTHER NUCLEIC ACID MATERIAL INTERROGATIONS Twinstrand Biosciences, Inc. (US) 2021-01-20 EP disclosed
US-20210010065-A1 METHODS AND REAGENTS FOR ENRICHMENT OF NUCLEIC ACID MATERIAL FOR SEQUENCING APPLICATIONS AND OTHER NUCLEIC ACID MATERIAL INTERROGATIONS TWINSTRAND BIOSCIENCES, INC. 2021-01-14 US disclosed
US-20200362390-A1 REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS TWINSTRAND BIOSCIENCES, INC. 2020-11-19 US disclosed
CN-111868255-A Methods and reagents for enriching nucleic acid material for sequencing applications and other nucleic acid material interrogation 特温斯特兰德生物科学有限公司 2020-10-30 CN disclosed
EP-3707273-A1 REAGENTS AND ADAPTERS FOR NUCLEIC ACID SEQUENCING AND METHODS FOR MAKING SUCH REAGENTS AND ADAPTERS Twinstrand Biosciences, Inc. (US) 2020-09-16 EP disclosed
WO-2019178577-A1 METHODS AND REAGENTS FOR ENRICHMENT OF NUCLEIC ACID MATERIAL FOR SEQUENCING APPLICATIONS AND OTHER NUCLEIC ACID MATERIAL INTERROGATIONS TWINSTRAND BIOSCIENCES, INC. (US) 2019-09-19 WO disclosed
US-20090104614-A1 QUANTITATIVE MOLECULAR PROBES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-04-23 US disclosed
WO-2007106900-A2 QUANTITATIVE MOLECULAR PROBES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2007-09-20 WO disclosed